剖宫产后个体化与标准化出院羟考酮处方比较:一项随机对照试验
该随机对照试验将172名剖宫产后女性按1:1分为标准组(30片5mg羟考酮)和个体化组(根据住院期间阿片类药物使用预测处方量)。个体化组处方片数更少(14 vs 30,P<.001),未使用片数较标准组减少50%(5 vs 10,P<.001),且患者报告的疼痛结局无显著差异。
要点
- 个体化组处方羟考酮片数中位数14片,标准组30片(P<.001)。
- 个体化组未使用片数中位数5片,较标准组10片减少50%(P<.001)。
- 两组患者报告的疼痛结局无显著差异。
核心结论
- 基于住院期间阿片类药物使用情况的个体化羟考酮处方与标准处方相比,减少了剖宫产后未使用的羟考酮片数。
研究设计与样本
- 随机对照试验,纳入18岁及以上行剖宫产的女性,出院时按1:1随机分为标准组(30片5mg羟考酮)或个体化组(根据每位患者住院期间阿片类药物使用预测处方量)。
- 共筛查323名女性,随机172名;样本量160名可检测两组 leftover tablets 30%差异,把握度80%,α=0.05。
- 主要结局为剖宫产后疼痛控制所处方未使用羟考酮片数;自剖宫产后14天起联系所有女性评估使用片数和疼痛控制充分性,并查询田纳西州管制物质监测数据库确认配发阿片类药物。
主要发现
- 个体化组处方片数中位数14片(四分位距12-16) vs 标准组30片(四分位距30-30),P<.001。
- 个体化组未使用片数中位数5片(四分位距1-8) vs 标准组10片(四分位距0-22),P<.001,个体化组较标准组减少50%。
- 总体13%(23/172)出院后未使用阿片类药物,26%(44/172)使用了全部处方阿片类药物;两组未使用阿片类药物或使用全部阿片类药物的比例无差异。
- 两组配发阿片类药物使用比例无差异:个体化组60%(四分位距23-100) vs 标准组61%(四分位距29-89),P=.93。
- 个体化组使用处方阿片类药物片数中位数8片(四分位距4-14) vs 标准组15片(四分位距6-30),P<.001,个体化组使用量为标准组的一半。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate whether individualized postdischarge oxycodone prescribing guided by inpatient opioid use reduces the number of unused opioid tablets after cesarean birth. METHODS: We conducted a randomized, controlled trial of women aged 18 years or older undergoing cesarean birth. Participants were randomized at discharge in a 1:1 ratio to a standard (30 tablets of 5 mg oxycodone) or an individualized oxycodone prescription (predicted based on each patient's inpatient opioid use). All women were contacted starting 14 days after cesarean birth to assess number of oxycodone tablets used and adequacy of pain control. The Tennessee Controlled Substance Monitoring Database was accessed to confirm dispensed opioids. The primary outcome was number of unused oxycodone tablets prescribed for pain control after cesarean birth. A total sample size of 160 women was necessary to detect a 30% difference in leftover tablets between groups with 80% power and α of 0.05. RESULTS: Between June 14, 2017, and August 26, 2017, we screened 323 women and randomized 172. Baseline characteristics and inpatient opioid use were similar between groups. Women in the individualized group were prescribed fewer tablets (14 [interquartile range 12-16] vs 30 [interquartile range 30-30], P<.001) and had 50% fewer unused tablets than women in the standard group (5 [interquartile range 1-8] vs 10 [interquartile range 0-22], P<.001). Overall, 13% (23/172) used no opioids after discharge and 26% (44/172) used all prescribed opioids. There were no differences between the standard and individualized groups in the proportion of women who used no opioids or all opioids and no difference in the proportion of dispensed opioids used (60% [interquartile range 23-100] vs 61% [29-89], P=.93). Women in the individualized group used only half the number of prescribed opioids as women in the standard group (8 [interquartile range 4-14] vs 15 [interquartile range 6-30], P<.001). Patient-reported pain outcomes did not differ significantly by group. CONCLUSION: Individualized opioid prescribing based on inpatient use reduces the number of unused oxycodone tablets compared with standard prescribing. CLINICAL TRIALS REGISTRATION: ClinicalTrials.gov, NCT03168425.
引用
- Osmundson SS, Raymond BL, Kook BT, et al. Individualized Compared With Standard Postdischarge Oxycodone Prescribing After Cesarean Birth: A Randomized Controlled Trial. Obstet Gynecol. 2018. PMID: 30095773. doi:10.1097/AOG.0000000000002782
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。